The chemical class of PTX3 Inhibitors encompasses a diverse array of compounds, each possessing unique properties that enable them to potentially downregulate or inhibit the activity of Pentraxin-related protein PTX3 (PTX3), a protein integral to the processes of inflammation and innate immunity. These inhibitors act not by directly targeting PTX3, but rather by influencing various cellular pathways that are indirectly linked to the regulation of PTX3. This class includes chemicals like hydrocortisone, a corticosteroid known to modulate the NF-κB pathway, a pivotal regulator in immune responses. The inhibition of NF-κB can potentially decrease PTX3 expression, given the pathway's involvement in PTX3 transcriptional activation. Similarly, nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and indomethacin inhibit cyclooxygenase enzymes, impacting prostaglandin synthesis and inflammatory pathways that might affect PTX3 expression. This indirect approach to PTX3 inhibition reflects the intricate and multi-layered nature of the pathways involved in its regulation.
Beyond these, the class includes a range of other compounds, each contributing to the potential inhibition of PTX3 through varied mechanisms. Compounds like apigenin, a flavonoid with anti-inflammatory properties, and celecoxib, a selective COX-2 inhibitor, demonstrate how diverse molecular structures can modulate similar pathways, leading to potential effects on PTX3 expression. Rapamycin, an immunosuppressant, inhibits the mechanistic target of rapamycin (mTOR) pathway, affecting cell growth and metabolism, which could indirectly impact PTX3. The inclusion of glucocorticoids, a broad class of corticosteroids, highlights the varied chemical structures within this class that can influence immune-related pathways and potentially modulate PTX3 activity. Additionally, compounds like tamoxifen and thalidomide, with their distinct actions on cellular signaling, expand the scope of this class. Even dietary components like omega-3 fatty acids and essential minerals like zinc are considered part of this class due to their roles in modulating immune function and inflammation, potentially leading to decreased PTX3 expression.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
A corticosteroid that modulates the NF-κB pathway, known for its anti-inflammatory properties. By inhibiting NF-κB, it could potentially decrease PTX3 expression, considering NF-κB's role in the transcriptional activation of PTX3. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $53.00 $88.00 | 6 | |
A nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis. Its effect on inflammatory pathways could potentially decrease PTX3 expression due to the involvement of these pathways in PTX3 regulation. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
A flavonoid with anti-inflammatory and antioxidant properties. It modulates various signaling pathways, including NF-κB. Through its action on these pathways, apigenin might have a role in decreasing PTX3 expression. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
Another NSAID that inhibits COX enzymes, affecting prostaglandin synthesis. Its role in modulating inflammation could lead to a decrease in PTX3 expression, given the link between inflammatory pathways and PTX3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An immunosuppressant that inhibits mTOR (mechanistic target of rapamycin), a key regulator of cell growth and metabolism. Its effect on immune and inflammatory responses could indirectly decrease PTX3 expression. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
A selective estrogen receptor modulator with known anti-inflammatory effects. Its influence on estrogen-mediated pathways could indirectly affect PTX3 expression. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Known for its immunomodulatory and anti-inflammatory properties. It affects multiple signaling pathways and could potentially decrease PTX3 expression through these mechanisms. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
An essential mineral with roles in immune function. It can influence immune-related pathways, potentially leading to a decrease in PTX3 expression. | ||||||